Đang chuẩn bị liên kết để tải về tài liệu:
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: A phase II, multicenter, single-arm study (SYSUCC-005)
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Despite significant survival improvement in human epidermal growth factor receptor 2 (HER2) blockade for HER2-positive breast cancer, resistance to anti-HER2 remains inevitable. |